Navigation Links
Lynn Kramer, MD, Appointed Chief Clinical Officer of Eisai Product Creation Systems
Date:4/11/2013

WOODCLIFF LAKE, N.J., April 11, 2013 /PRNewswire/ -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announces the immediate appointment of Lynn Kramer , MD, to the newly created position of chief clinical officer of Eisai Product Creation Systems. In this role, Dr. Kramer will be responsible for the approval of protocol designs of pivotal studies to achieve timely regulatory approval of competitive labels for new products, indications and life-cycle extensions. This includes the selection of study regions and clinical sites. He also will provide oversight of the design of Proof of Concept (POC) Studies for each of Eisai's Product Creation Units.

(Logo: http://photos.prnewswire.com/prnh/20120413/MM87168LOGO )

In addition to these new responsibilities, Dr. Kramer will continue to serve as president of the Neuroscience and General Medicine Product Creation Unit, a position he has held since July 2009. In this capacity, he is responsible for overseeing the full product creation cycle from discovery through regulatory approval of innovative projects in the neuroscience and general medicine areas. 

Dr. Kramer joined Eisai in 2007 as executive vice president of Global Clinical Research and was soon promoted to the additional role of COO of Eisai Medical Research. Upon the establishment of Eisai Product Creation Systems in 2009, he accepted a dual appointment as president of the Neuroscience and General Medicine Product Creation Unit and also the Scientific and Operational Clinical Support (SOCS) Core Functional Unit. He held the SOCS position until mid-2010.

Dr. Kramer is a Fellow of the American Board of Psychiatry and Neurology. He currently serves as the industry representative on the Peripheral and Central Nervous System Drugs Advisory Committee of the Food and Drug Administration and is on the Board of Directors of the American Society for Experimental NeuroTherapeutics (ASENT). Dr. Kramer also has been appointed to the newly established Scientific Leadership Advisory Council of the Pharmaceutical Research and Manufacturers of America (PhRMA).  

Dr. Kramer received his MD from Hahnemann Medical College. He completed his internship in internal medicine at the University of California at Irvine and his residency in neurology at the University of Virginia. Dr. Kramer also holds a Bachelor of Arts from Lycoming College, where he has since been named to the Board of Trustees. 

Eisai Inc.
Eisai Inc. was established in 1995 and began marketing its first product in the United States in 1997. Since that time, Eisai Inc. has rapidly grown to become a fully integrated pharmaceutical business. Eisai's key areas of commercial focus are neurology and oncology. The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.

Eisai has a global product creation organization that includes U.S.-based R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania, as well as manufacturing facilities in Maryland and North Carolina. The company's areas of R&D focus include neuroscience; oncology; vascular, inflammatory and immunological reaction; and antibody-based programs. For more information about Eisai, please visit www.eisai.com/US.

Eisai Co., Ltd.
Eisai Co., Ltd. is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system.

Media Inquiries
Suzanne Grogan
201-746-2083
suzanne_grogan@eisai.com


'/>"/>
SOURCE Eisai Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ken Mulvany Appointed Chairman of The Cure Parkinsons Trust
2. David Norton Appointed to TB Alliances Board of Directors
3. Searcy Denney Scarola Barnhart & Shipley Attorney Appointed to Plaintiffs Steering Committee for Stryker Hip Implant Litigation
4. Graham Cooper Appointed Chief Financial Officer of Receptos
5. Gregory D. Cash Appointed President and Chief Executive Officer of NeuroTherm
6. Doug Pepper appointed as Chief Financial Officer at Cardiac Science
7. Erich R. Reinhardt Appointed to Board of Directors of Varian Medical Systems
8. United Spinal Appointed to U.S. Access Board: Developing Accessible Standards for Medical Diagnostic Equipment
9. Micross Components Appointed as Global Specialist Die Distributor to International Rectifier
10. Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
11. Neal K. Long appointed as Chief Executive Officer at Cardiac Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... , Dec. 9, 2016  Nevro Corp. (NYSE: ... is providing innovative evidence-based solutions for the treatment of ... BSX ) has filed a lawsuit for patent ... Court for the District of Delaware ... covering technology related to stimulation leads, batteries, and telemetry ...
(Date:12/9/2016)... MSD, a nationally recognized supplier of technology ... site health care facilities, announced today that it has ... Choice"), a privately held national distributor of medical supplies ... health segments. We would like to welcome First Choice ... transaction will deliver significant and immediate value to MSD,s ...
(Date:12/9/2016)... , December 9, 2016 ... ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy ... Wearable Cardioverter Defibrillators The global ... a CAGR of 5.3% from 2016-2020 and CAGR ... to grow at a CAGR of 5.2% from ...
Breaking Medicine Technology:
(Date:12/10/2016)... ... 10, 2016 , ... When faced with having to use a toilet away ... to her body, and contamination of children when they use public toilets. This inspired ... that many people face. , The patent-pending SANI-POCKET enables a person to use a ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... planning assistance from offices in Pasco and Richland, is initiating a charity drive ... serious injuries resulting from a recent automobile collision. , On October 29th ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... miniature, folded, pharmaceutical inserts and outserts. As a means of expanding capabilities ... addition will enable Flottman to individually code professional inserts (PIs) and patient package ...
(Date:12/9/2016)... Heights, NY (PRWEB) , ... December 09, 2016 , ... ... Alcoholism and Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits ... states and the District of Columbia as an education tool in the war against ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted to ... types of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. ... and could be set up in a matter of minutes, or even seconds. The ...
Breaking Medicine News(10 mins):